Adding cediranib to chemotherapy improves progression-free survival for metastatic or recurrent cervical cancer, phase II trial shows
This item is under embargo and is only visible to journalists
Please login here
Regions: Europe, United Kingdom, Switzerland
Keywords: Health, Medical, Public Dialogue - health
The item has been withdrawn. If you are a journalists please contact the person that posted the item with any questions.